No progression of subclinical atherosclerosis in...

No progression of subclinical atherosclerosis in HIV-infected patients starting an initial regimen including tenofovir alafenamide/emtricitabine plus raltegravir, dolutegravir or elvitegravir/cobicistat during a two-year follow-up

Calza, Leonardo, Borderi, Marco, Colangeli, Vincenzo, Borioni, Aurora, Coladonato, Simona, Granozzi, Bianca, Viale, Pierluigi
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Journal:
Infectious Diseases
DOI:
10.1080/23744235.2019.1707279
Date:
December, 2019
File:
PDF, 915 KB
2019
Conversion to is in progress
Conversion to is failed